Fairchem Organics shares hit an upper circuit limit of ₹806.50, representing a 5% surge from the previous closing price of ₹768.1. According to latest reports, the stock reached this level after the company reported exceptional earnings growth for the quarter ended June 30, 2026. The company, with a market capitalization of ₹1,015 crore, trades at a P/E ratio of 174.62 and operates in the specialty chemicals space with manufacturing focus on oleo chemicals and intermediate nutraceuticals.
The company's standalone profit after tax surged 755.56% year-on-year and 171.27% quarter-on-quarter to ₹10.01 crore in Q1 FY27. As reported by Business Standard, this dramatic increase in profitability demonstrates the company's strong operational performance during the quarter. The profit before tax stood at ₹13.64 crore, up 741.98% YoY and 188.37% QoQ from ₹1.62 crore in the same quarter last year. Earnings per share (EPS) for the quarter stood at ₹7.95, compared to ₹0.90 in the year-ago quarter and ₹2.85 in the preceding quarter.
Revenue from operations increased 34.40% YoY and 50.64% QoQ to ₹176.15 crore in the quarter ended June 30, 2026, compared to ₹131.06 crore in Q1 FY26 and ₹116.93 crore in Q4 FY26. According to Business Standard, this substantial revenue growth indicates strong demand for the company's specialty chemicals and nutraceutical ingredients. The company's diversified portfolio spans oleochemicals, food, personal care, pharmaceutical and industrial sectors, with nearly all revenue coming from domestic sales within India.
Total expenses increased 25.68% YoY to ₹162.86 crore from ₹129.58 crore, with cost of materials consumed rising 32.60% YoY to ₹120.27 crore from ₹90.73 crore. As reported by Business Standard, employee benefits expense increased 12.50% YoY to ₹6.75 crore, while finance costs climbed significantly by 84% YoY to ₹1.84 crore from ₹1.01 crore. Power and fuel expenses rose modestly by 5.12% YoY to ₹6.98 crore, and depreciation and amortisation expenses increased marginally by 0.37% YoY to ₹2.74 crore. However, revenue growth outpaced the rise in costs, helping expand operating margins.
As of June 30, 2026, promoter holding increased to 63.25% from 61.20% in the same quarter last year, reflecting continued confidence from the promoter group. Foreign Institutional Investors (FIIs) held a stable stake at 6.34%, broadly unchanged from 6.28% a year earlier. However, Domestic Institutional Investors (DIIs) saw their holding decline sharply to 2.80% from 5.77% in the year-ago quarter. Public shareholding rose to 27.60% from 26.76% over the same period. The total number of shareholders also declined to 25,690 as of June 2026, compared to 29,051 in the corresponding quarter last year.
